NextGen Omics US

Westin Boston Seaport District Hotel, 425 Summer Street, Boston, MA 02210 United States

NanoString is thrilled to be heading to Boston as the Diamond Sponsor of NextGen Omics, March 21-22! During the conference we have a number of exciting activities to highlight how GeoMx DSP and CosMx SMI are pushing the boundaries of spatial biology insights.

The NextGen Omics Conference unites 450+ thought leaders from global academic & research institutions and pharmaceutical companies, some benefits to attending are:

  • Take a deep dive into clinical genomics and diagnostics
  • Discuss novel spatial analysis technologies and their applications in research and therapeutics
  • Advance your understanding on single cell omics and multi omics analysis
  • And More!

Friday, March 22 | 9:00 – 10:30 am ET

9:00 AMWelcome & IntroductionEspy Anguiano, PhD, NanoString Technologies
9:10 AM Spatial transcriptomic profiling of non-small cell lung cancer to discover novel drivers of tumor-mediated immune evasionChristina Cho, PhD, Yale Medical School
9:35 AMEstablishing a Single-cell & Spatial Biology Center of Excellence as a CRO Service ProviderLori Mull, PhD, Psomagen
10:00 AMSpatial Data Analysis Workshop Prajan Divakar, PhD, NanoString Technologies
10:20Industry Panel Discussion


Christina Cho, PhD

Associate Research Scientist, Yale School of Medicine

Lori Mull, PhD

Sr. Product Manager, Spatial Biology and Proteomics, Psomagen

Sayani Bhattacharjee, PhD, Field Application Scientist headshot

Sayani Bhattacharjee, PhD

Field Application Scientist, NanoString Technologies

Sayani Bhattacharjee, PhD, is a Field Application Scientist for NanoString Technologies. She earned her PhD in Biomedical Science from the University of Toledo and has a strong background in translational cancer research and molecular biology. Sayani lives in Pennsylvania but supports customers in New York and New Jersey as well as customers in Pennsylvania.

Prajan Divakar, Ph.D.

Director, Spatial Systems, NanoString Technologies

Espy Anguiano, PhD, MS-MBA

Scientific Market Development Director for Biopharma, NanoString

Dr. Espy Anguiano, Scientific Market Development Director at NanoString, obtained her PhD in Biomedical Science from Baylor University and holds a dual MBA degree from Temple University. She has over 20 years of experience in translational and clinical biomarker research in both academic and industry settings. Dr. Anguiano is a biomarker technology subject matter expert and has led biomarker and biomarker technology strategies for many early- and late-phase clinical trials in oncology and non-oncology disease areas. In her current role at NanoString, she is responsible for enabling the successful adoption of bulk and spatial technologies in research activities supporting drug discovery and development.